By HotStockRockets | Saturday 22 November 2014
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
We tipped shares in Optiobiotix (LSE:OPTI) just a few months ago at a 9p offer. Knock me down with a feather they closed Friday at 20.75p-21.25p. But the fun is not over yet. We urged you strongly a week ago to buy at up to our limit buy price of 15p as the last chance to get in cheap. We hope that advice was taken even if you ignored the original tip.
Our stated target price is 30p but following a chat on Friday with a well-connected individual we reckon that the shares could head higher than that on short order. For one of the things about Optibiotix is that the share register is pretty tight. Unlike many penny stocks it has not issued shares like confetti and has no need to issue shares.
So what are we expecting in the next few weeks? We hope for further strengthening of the board. We hope for more news out of Nizo, the Dutch firm testing Optibiotix products in yoghurt and… well here’s the big daddy…
We know that the company is talking to really big name multi nationals about deals which would in scale be massive relative to the current market capitalisation as you can see illustrated HERE. Let’s see how rapidly those talks progress. This is certainly not one to be selling. Its fireworks by Christmas on this share tip.
The HotStockRockets share tip of the month will be published next Friday. To access this service for as little as £5 sign up HERE
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |